HealthEquity (NASDAQ:HQY) Stock Rating Upgraded by Raymond James

HealthEquity (NASDAQ:HQY) was upgraded by analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage presently has a $115.00 target price on the stock, down from their previous target price of $120.00. Raymond James’ price target would indicate a potential upside of 28.89% from the company’s current price.

HQY has been the subject of a number of other research reports. Barrington Research restated an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a research report on Friday, March 14th. KeyCorp cut their price target on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price for the company. Finally, JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $113.31.

HealthEquity Price Performance

HQY stock opened at $89.22 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company’s fifty day moving average price is $104.17 and its 200-day moving average price is $95.89. HealthEquity has a one year low of $65.01 and a one year high of $115.59. The company has a market capitalization of $7.72 billion, a PE ratio of 81.85, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently added to or reduced their stakes in HQY. Ameritas Investment Partners Inc. boosted its stake in HealthEquity by 0.3% in the fourth quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock valued at $3,248,000 after acquiring an additional 88 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after purchasing an additional 98 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in shares of HealthEquity by 0.4% in the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after purchasing an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after buying an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System increased its position in HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock valued at $1,988,000 after buying an additional 100 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.